Reproductive rights advocates breathed a sigh of relief on Thursday after the U.S. Supreme Court dismissed a lawsuit attempting to restrict access to the abortion pill mifepristone and telehealth abortion nationwide.

“While the Supreme Court did the bare minimum today, we know anti-abortion extremists aren’t stopping any time soon.”

The fall 2024 elections are critical to maintaining abortion pills access. The president appoints the head of the FDA, who controls the status of mifepristone. A Trump administration could rescind the FDA’s recent expansions of access to abortion pills or even try to withdraw mifepristone from the market altogether.